Phocaeicola Vulgatus Test · Stool

Most gut tests give you a long list of bacteria without telling you which ones actually matter. Phocaeicola vulgatus is one that does. It sits at the center of how your gut handles inflammation, certain medications, and even how your immune system reacts to your own tissues.

Knowing your level matters because this single bacterium has been tied to things as different as how well metformin lowers your blood sugar, how severe ulcerative colitis becomes, and how likely a person with cirrhosis is to develop confusion after a liver procedure. The same bug can be helpful in one body and harmful in another, which is why a number on a stool report deserves real interpretation.

What This Bacterium Actually Is

P. vulgatus (Phocaeicola vulgatus, formerly called Bacteroides vulgatus) is a Gram-negative anaerobic bacterium, meaning it lives without oxygen and has a particular outer wall structure. It is one of the most common species in the Bacteroidaceae family, a group that makes up a large share of the bacteria in the adult colon.

It shows up early in life. Infants begin acquiring P. vulgatus and related Bacteroidaceae species within the first months, often from their mothers, and it remains a frequent resident in healthy adults across many regions. It feeds on carbohydrates, produces short-chain fatty acids that calm the gut lining, and can also produce proteases (enzymes that break down proteins) that, in some people, irritate the colon.

The Two Faces of P. vulgatus

This is not a simple "good bug" or "bad bug." Depending on the host, it can protect or harm. The same species has been linked to lower atherosclerosis in some studies and to worse colitis or worse diabetes control in others. The reason is context: which strain you carry, what enzymes it produces, what your bile acids look like, and whether your gut barrier is intact all change the story.

Heart Disease

In coronary artery disease, P. vulgatus tends to be lower than in healthy controls. Giving live P. vulgatus to mice reduced atherosclerosis and lowered the inflammatory load coming from gut bacteria. In a 12-week program of caloric restriction plus strength and high-intensity training in adults with obesity, P. vulgatus rose alongside improved body composition and liver enzymes.

Type 2 Diabetes and Metformin Response

This is where the data get most actionable. In newly diagnosed type 2 diabetes, people whose blood sugar did not respond well to metformin had roughly 12 times more P. vulgatus in their stool than people who responded. In animal experiments, colonizing the gut with P. vulgatus undid metformin's benefits by altering bile acids and ceramides (a type of fat that affects how cells use energy) and disrupting mitochondria, the energy-producing parts of cells.

What this means for you: if you are starting metformin or already on it and your numbers are not budging, your gut composition may be one of the reasons, and P. vulgatus is one of the bacteria worth checking.

Inflammatory Bowel Disease

In ulcerative colitis, a subset of patients carry P. vulgatus strains that produce unusually active proteases. These enzymes damage the colon lining and were tied to greater disease severity in a multi-cohort study. Inhibiting these proteases reduced colitis in animals, suggesting the species itself is not the problem so much as what some strains are doing.

Liver Disease and Hepatic Encephalopathy

In people with cirrhosis who undergo a procedure called TIPS (transjugular intrahepatic portosystemic shunt), higher P. vulgatus before and after the procedure tracked with higher blood ammonia and a higher risk of hepatic encephalopathy, a confusion state caused by toxins the liver normally clears. In that study, P. vulgatus was one of the strongest microbial predictors of who developed this complication.

Bone Health

Higher P. vulgatus abundance has been linked to lower bone mineral density. Mouse work supports a causal role through valeric acid (a short-chain fatty acid) and related metabolites, suggesting that this bacterium can quietly influence skeletal strength.

Polycystic Ovary Syndrome

In women with PCOS (polycystic ovary syndrome, a hormonal condition that disrupts ovulation), P. vulgatus was elevated. In animal models, transferring this bacterium worsened insulin resistance and ovarian dysfunction, working through bile acid changes and an immune signal called interleukin-22.

Sepsis and Severe Infection

In hospitalized adults with sepsis, a higher burden of P. vulgatus was associated with greater illness severity and longer ICU stays. In rare cases, when this bacterium escapes the gut after surgery or barrier breakdown, it can cause serious bloodstream infections, abdominal abscesses, and even septic shock.

Post-Cholecystectomy Diarrhea

In a study of patients who had their gallbladder removed, P. vulgatus was markedly enriched in the subgroup who developed persistent diarrhea afterward, pointing to a possible microbial driver of this common surgical side effect.

Reconciling the Contradictions

This is not a marker where higher always means worse or lower always means better. P. vulgatus is a phenotype indicator. Its impact depends on which strain you carry, what enzymes that strain produces, the state of your bile acids, your gut barrier integrity, and what medications you are taking. The same number can be reassuring in one person and concerning in another, which is why it should always be interpreted alongside other markers and your clinical picture.

Reference Ranges

P. vulgatus is a research and exploratory marker. There are no standardized clinical cutpoints, no consensus reference intervals from major guidelines, and no validated thresholds tied to specific outcomes. The numbers below describe how the species is generally observed in research populations and are not diagnostic targets.

Because no clinical reference ranges exist, compare your results within the same lab over time. The trend in your own gut, especially before and after an intervention, is far more meaningful than how your single number compares to anyone else's.

Tracking Your Trend

Gut bacteria shift in response to diet, medications, illness, and time of year. A single stool reading captures a moment, not a pattern. The most useful way to use this measurement is to take a baseline, repeat it 3 to 6 months later if you are making changes (a new diet, a new medication, a new exercise program), and then check again at least annually.

Serial trending matters even more here than for many blood tests because your microbiome's day-to-day variability is real and not fully characterized for this species. One high reading is information. Two high readings, separated by months, is a pattern worth acting on.

What to Do With an Abnormal Result

If your P. vulgatus is markedly high and you are on metformin without good blood sugar response, consider discussing the result with your physician along with HbA1c, fasting insulin, and a broader stool panel. Higher levels alongside symptoms of inflammatory bowel disease (chronic diarrhea, blood in stool, abdominal pain) are worth bringing to a gastroenterologist, who can evaluate further with calprotectin, colonoscopy, or protease-related testing.

If you have cirrhosis, especially if you are being evaluated for or have had a TIPS procedure, share the result with your hepatologist. If your level is low and you have known cardiovascular disease, that pattern is more of a research observation than an action item right now.

When Results Can Be Misleading

• Recent antibiotics: any antibiotic in the prior weeks can sharply alter your stool composition and make a single reading unrepresentative.
• New medications: starting metformin, proton pump inhibitors, or GLP-1 agonists in the weeks before testing can shift gut bacteria, including P. vulgatus, before steady state is reached.
• Acute illness: a recent infection, hospitalization, or significant gastrointestinal upset can transiently change your microbiome and skew results.
• Major dietary shifts: starting a new eating pattern in the days before sampling can move bacterial abundances in ways that do not reflect your usual baseline.

For the most useful reading, sample when your diet, medications, and health are at a typical steady state, and avoid sampling within two weeks of finishing antibiotics.